JP2005533148A - 生分解性の相分離したセグメント化多ブロック共重合体 - Google Patents
生分解性の相分離したセグメント化多ブロック共重合体 Download PDFInfo
- Publication number
- JP2005533148A JP2005533148A JP2004521291A JP2004521291A JP2005533148A JP 2005533148 A JP2005533148 A JP 2005533148A JP 2004521291 A JP2004521291 A JP 2004521291A JP 2004521291 A JP2004521291 A JP 2004521291A JP 2005533148 A JP2005533148 A JP 2005533148A
- Authority
- JP
- Japan
- Prior art keywords
- prepolymer
- copolymer
- copolymer according
- caprolactone
- phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920006030 multiblock copolymer Polymers 0.000 title claims abstract description 16
- 229920001577 copolymer Polymers 0.000 claims abstract description 169
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 claims description 67
- 239000000178 monomer Substances 0.000 claims description 53
- 239000004970 Chain extender Substances 0.000 claims description 39
- 229920001610 polycaprolactone Polymers 0.000 claims description 35
- 229920000642 polymer Polymers 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 26
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims description 18
- 229920001223 polyethylene glycol Polymers 0.000 claims description 18
- 239000002202 Polyethylene glycol Substances 0.000 claims description 17
- 238000009826 distribution Methods 0.000 claims description 17
- 238000006243 chemical reaction Methods 0.000 claims description 16
- 150000002009 diols Chemical class 0.000 claims description 14
- 239000002253 acid Substances 0.000 claims description 13
- 229920000570 polyether Polymers 0.000 claims description 13
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 11
- 125000001931 aliphatic group Chemical group 0.000 claims description 11
- 230000001588 bifunctional effect Effects 0.000 claims description 11
- -1 cyclic acid anhydrides Chemical class 0.000 claims description 11
- OZJPLYNZGCXSJM-UHFFFAOYSA-N 5-valerolactone Chemical compound O=C1CCCCO1 OZJPLYNZGCXSJM-UHFFFAOYSA-N 0.000 claims description 10
- 210000005036 nerve Anatomy 0.000 claims description 10
- 150000002148 esters Chemical class 0.000 claims description 9
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 8
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 8
- 239000004005 microsphere Substances 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- 125000004122 cyclic group Chemical group 0.000 claims description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 6
- 239000003999 initiator Substances 0.000 claims description 6
- 238000007151 ring opening polymerisation reaction Methods 0.000 claims description 6
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical group C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- 125000005442 diisocyanate group Chemical group 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical group O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000012377 drug delivery Methods 0.000 claims description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 claims description 4
- 125000002015 acyclic group Chemical group 0.000 claims description 3
- 125000005587 carbonate group Chemical group 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 claims description 3
- 239000007943 implant Substances 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 claims description 3
- VKSWWACDZPRJAP-UHFFFAOYSA-N 1,3-dioxepan-2-one Chemical compound O=C1OCCCCO1 VKSWWACDZPRJAP-UHFFFAOYSA-N 0.000 claims description 2
- KKGSHHDRPRINNY-UHFFFAOYSA-N 1,4-dioxan-2-one Chemical compound O=C1COCCO1.O=C1COCCO1 KKGSHHDRPRINNY-UHFFFAOYSA-N 0.000 claims description 2
- VPVXHAANQNHFSF-UHFFFAOYSA-N 1,4-dioxan-2-one Chemical compound O=C1COCCO1 VPVXHAANQNHFSF-UHFFFAOYSA-N 0.000 claims description 2
- AOLNDUQWRUPYGE-UHFFFAOYSA-N 1,4-dioxepan-5-one Chemical compound O=C1CCOCCO1 AOLNDUQWRUPYGE-UHFFFAOYSA-N 0.000 claims description 2
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 claims description 2
- JPSKCQCQZUGWNM-UHFFFAOYSA-N 2,7-Oxepanedione Chemical compound O=C1CCCCC(=O)O1 JPSKCQCQZUGWNM-UHFFFAOYSA-N 0.000 claims description 2
- SJZRECIVHVDYJC-UHFFFAOYSA-N 4-hydroxybutyric acid Chemical compound OCCCC(O)=O SJZRECIVHVDYJC-UHFFFAOYSA-N 0.000 claims description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 2
- 239000001361 adipic acid Substances 0.000 claims description 2
- 235000011037 adipic acid Nutrition 0.000 claims description 2
- 229920005576 aliphatic polyanhydride Polymers 0.000 claims description 2
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 claims description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical group O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 2
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 claims description 2
- 239000004310 lactic acid Substances 0.000 claims description 2
- 235000014655 lactic acid Nutrition 0.000 claims description 2
- FDYWJVHETVDSRA-UHFFFAOYSA-N 1,1-diisocyanatobutane Chemical compound CCCC(N=C=O)N=C=O FDYWJVHETVDSRA-UHFFFAOYSA-N 0.000 claims 2
- 239000007795 chemical reaction product Substances 0.000 claims 2
- 150000001991 dicarboxylic acids Chemical class 0.000 claims 2
- 229920001451 polypropylene glycol Polymers 0.000 claims 2
- BJZYYSAMLOBSDY-QMMMGPOBSA-N (2s)-2-butoxybutan-1-ol Chemical compound CCCCO[C@@H](CC)CO BJZYYSAMLOBSDY-QMMMGPOBSA-N 0.000 claims 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims 1
- 239000011888 foil Substances 0.000 claims 1
- 230000005499 meniscus Effects 0.000 claims 1
- 229920000909 polytetrahydrofuran Polymers 0.000 claims 1
- 230000007704 transition Effects 0.000 abstract description 14
- 229920001169 thermoplastic Polymers 0.000 abstract description 4
- 239000004416 thermosoftening plastic Substances 0.000 abstract description 4
- 239000012071 phase Substances 0.000 description 66
- 229920000728 polyester Polymers 0.000 description 49
- 238000002844 melting Methods 0.000 description 33
- 230000008018 melting Effects 0.000 description 33
- 239000000203 mixture Substances 0.000 description 33
- 229920005604 random copolymer Polymers 0.000 description 30
- 229920001634 Copolyester Polymers 0.000 description 22
- 238000005191 phase separation Methods 0.000 description 21
- 238000006116 polymerization reaction Methods 0.000 description 17
- 239000000243 solution Substances 0.000 description 16
- 229920001400 block copolymer Polymers 0.000 description 15
- 239000000463 material Substances 0.000 description 13
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- 230000015556 catabolic process Effects 0.000 description 9
- 238000006731 degradation reaction Methods 0.000 description 9
- 238000000113 differential scanning calorimetry Methods 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- 238000005160 1H NMR spectroscopy Methods 0.000 description 8
- 239000010432 diamond Substances 0.000 description 7
- 230000009477 glass transition Effects 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000003708 ampul Substances 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 239000012299 nitrogen atmosphere Substances 0.000 description 6
- 238000005809 transesterification reaction Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 description 5
- 229920002732 Polyanhydride Polymers 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 229920000954 Polyglycolide Polymers 0.000 description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 229920000515 polycarbonate Polymers 0.000 description 4
- 239000004417 polycarbonate Substances 0.000 description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- KSBAEPSJVUENNK-UHFFFAOYSA-L tin(ii) 2-ethylhexanoate Chemical compound [Sn+2].CCCCC(CC)C([O-])=O.CCCCC(CC)C([O-])=O KSBAEPSJVUENNK-UHFFFAOYSA-L 0.000 description 4
- OVBFMUAFNIIQAL-UHFFFAOYSA-N 1,4-diisocyanatobutane Chemical compound O=C=NCCCCN=C=O OVBFMUAFNIIQAL-UHFFFAOYSA-N 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 3
- PBAYDYUZOSNJGU-UHFFFAOYSA-N chelidonic acid Natural products OC(=O)C1=CC(=O)C=C(C(O)=O)O1 PBAYDYUZOSNJGU-UHFFFAOYSA-N 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- 229920001519 homopolymer Polymers 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 230000004962 physiological condition Effects 0.000 description 3
- 229920001432 poly(L-lactide) Polymers 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 125000006832 (C1-C10) alkylene group Chemical group 0.000 description 2
- ZAJGKKXBKLVSKW-UHFFFAOYSA-N 3,6-dimethyl-1,4-dioxane-2,5-dione;oxepan-2-one Chemical compound O=C1CCCCCO1.CC1OC(=O)C(C)OC1=O ZAJGKKXBKLVSKW-UHFFFAOYSA-N 0.000 description 2
- 229920001244 Poly(D,L-lactide) Polymers 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 238000012662 bulk polymerization Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229920005684 linear copolymer Polymers 0.000 description 2
- 125000005647 linker group Chemical group 0.000 description 2
- 238000002406 microsurgery Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000007142 ring opening reaction Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 229920002725 thermoplastic elastomer Polymers 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 208000005422 Foreign-Body reaction Diseases 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 229920005603 alternating copolymer Polymers 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229920005605 branched copolymer Polymers 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001938 differential scanning calorimetry curve Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000012633 leachable Substances 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000006069 physical mixture Substances 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229920006126 semicrystalline polymer Polymers 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000000807 solvent casting Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 239000012815 thermoplastic material Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N urethane group Chemical group NC(=O)OCC JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/42—Polycondensates having carboxylic or carbonic ester groups in the main chain
- C08G18/4266—Polycondensates having carboxylic or carbonic ester groups in the main chain prepared from hydroxycarboxylic acids and/or lactones
- C08G18/4269—Lactones
- C08G18/4277—Caprolactone and/or substituted caprolactone
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/42—Polycondensates having carboxylic or carbonic ester groups in the main chain
- C08G18/4266—Polycondensates having carboxylic or carbonic ester groups in the main chain prepared from hydroxycarboxylic acids and/or lactones
- C08G18/428—Lactides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
- C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
- C08G63/08—Lactones or lactides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
- C08G63/60—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from the reaction of a mixture of hydroxy carboxylic acids, polycarboxylic acids and polyhydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/64—Polyesters containing both carboxylic ester groups and carbonate groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/66—Polyesters containing oxygen in the form of ether groups
- C08G63/664—Polyesters containing oxygen in the form of ether groups derived from hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
- C08L67/04—Polyesters derived from hydroxycarboxylic acids, e.g. lactones
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2230/00—Compositions for preparing biodegradable polymers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Polyesters Or Polycarbonates (AREA)
- Materials For Medical Uses (AREA)
- Biological Depolymerization Polymers (AREA)
- Medicinal Preparation (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Polyurethanes Or Polyureas (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02077878A EP1382628A1 (en) | 2002-07-16 | 2002-07-16 | Biodegradable phase separated segmented/block co-polyesters |
| PCT/NL2003/000519 WO2004007588A1 (en) | 2002-07-16 | 2003-07-16 | Biodegradable phase separated segmented multi block co-polymers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005533148A true JP2005533148A (ja) | 2005-11-04 |
| JP2005533148A5 JP2005533148A5 (enExample) | 2006-08-24 |
Family
ID=29762686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004521291A Pending JP2005533148A (ja) | 2002-07-16 | 2003-07-16 | 生分解性の相分離したセグメント化多ブロック共重合体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8674033B2 (enExample) |
| EP (2) | EP1382628A1 (enExample) |
| JP (1) | JP2005533148A (enExample) |
| CN (1) | CN1675281B (enExample) |
| AT (1) | ATE394439T1 (enExample) |
| AU (1) | AU2003247231B2 (enExample) |
| CA (1) | CA2493375C (enExample) |
| DE (1) | DE60320819D1 (enExample) |
| ES (1) | ES2305512T3 (enExample) |
| WO (1) | WO2004007588A1 (enExample) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005320426A (ja) * | 2004-05-07 | 2005-11-17 | National Institute For Materials Science | ポリリンゴ酸共重合体の製造方法 |
| JPWO2006100844A1 (ja) * | 2005-03-18 | 2008-08-28 | 三井化学株式会社 | 生分解性を有する水環境応答型ポリマー、その製造方法および水崩壊性材料 |
| JP2010506991A (ja) * | 2006-10-18 | 2010-03-04 | コントロールド・セラピューティクス(スコットランド)・リミテッド | 生体吸収性ポリマー |
| WO2010101240A1 (ja) * | 2009-03-06 | 2010-09-10 | 国立大学法人岡山大学 | 生分解性多孔質中空微粒子、その製造方法および用途 |
| WO2012133608A1 (ja) * | 2011-03-30 | 2012-10-04 | 東レ株式会社 | 生分解性粒子、血管塞栓材料及び生分解性粒子の製造方法 |
| JP2014521762A (ja) * | 2011-07-22 | 2014-08-28 | インノコア テクノロジーズ ビー.ブイ. | 生物活性化合物の制御放出のための生物分解性、半結晶性、相分離、熱可塑性マルチブロックコポリマー |
| JP2015511649A (ja) * | 2012-03-12 | 2015-04-20 | エシコン・インコーポレイテッドEthicon, Inc. | セグメント化した、半結晶性ポリ(ラクチド−コ−ε−カプロラクトン)吸収性コポリマー |
| WO2020122096A1 (ja) * | 2018-12-13 | 2020-06-18 | 東レ株式会社 | 医療用成形体、医療機器、神経再生誘導チューブ |
| JP2022540717A (ja) * | 2019-07-19 | 2022-09-16 | エボニック オペレーションズ ゲーエムベーハー | マルチブロック形状記憶生体吸収性ポリマー |
| WO2024029491A1 (ja) * | 2022-08-01 | 2024-02-08 | Dic株式会社 | 3-ヒドロキシ酪酸からなるコポリエステル及びその製造方法 |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8685431B2 (en) * | 2004-03-16 | 2014-04-01 | Advanced Cardiovascular Systems, Inc. | Biologically absorbable coatings for implantable devices based on copolymers having ester bonds and methods for fabricating the same |
| US8357391B2 (en) * | 2004-07-30 | 2013-01-22 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable devices comprising poly (hydroxy-alkanoates) and diacid linkages |
| JP2008508414A (ja) | 2004-08-02 | 2008-03-21 | サムヤン コーポレーション | ゾル−ゲル遷移が可能な生分解性多重ブロック高分子組成物、及びこれを含有する薬学的組成物 |
| DE102005033101A1 (de) | 2005-07-15 | 2007-01-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Resorbierbare Polyetherester und ihre Verwendung zur Herstellung von medizinischen Implantaten |
| US20070233219A1 (en) * | 2006-02-16 | 2007-10-04 | Bilal Shafi | Polymeric heart restraint |
| US9028859B2 (en) * | 2006-07-07 | 2015-05-12 | Advanced Cardiovascular Systems, Inc. | Phase-separated block copolymer coatings for implantable medical devices |
| EP3009477B1 (en) | 2006-07-20 | 2024-01-24 | Orbusneich Medical Pte. Ltd | Bioabsorbable polymeric composition for a medical device |
| EP2049591A4 (en) * | 2006-08-02 | 2009-08-19 | Polynovo Biomaterials Pty Ltd | BIOKOMPATIBLE POLYMERIC COMPOSITIONS |
| EP2076211A4 (en) * | 2006-10-20 | 2015-07-22 | Elixir Medical Corp | LUMINOUS PROSTHESES AND METHODS OF COATING THEREOF |
| EP2073754A4 (en) | 2006-10-20 | 2012-09-26 | Orbusneich Medical Inc | BIOABSORBABLE POLYMER COMPOSITION AND MEDICAL DEVICE BACKGROUND |
| US7959942B2 (en) | 2006-10-20 | 2011-06-14 | Orbusneich Medical, Inc. | Bioabsorbable medical device with coating |
| DE102006058755A1 (de) * | 2006-12-08 | 2008-06-12 | Gkss-Forschungszentrum Geesthacht Gmbh | Verfahren zur Herstellung eines alternierenden Multiblockcopolymers mit Formgedächtnis |
| US8501290B2 (en) | 2008-01-15 | 2013-08-06 | Abbott Cardiovascular Systems Inc. | Implantable medical devices fabricated from polyurethanes with biodegradable hard and soft blocks and blends thereof |
| ATE548285T1 (de) | 2008-01-29 | 2012-03-15 | James Alexander Corp | Spender |
| US9259515B2 (en) | 2008-04-10 | 2016-02-16 | Abbott Cardiovascular Systems Inc. | Implantable medical devices fabricated from polyurethanes with grafted radiopaque groups |
| US20090326642A1 (en) * | 2008-06-25 | 2009-12-31 | Yunbing Wang | Implantable Medical Devices Fabricated From Radiopaque Polymers With High Fracture Toughness |
| CN101531756B (zh) * | 2009-04-16 | 2011-06-15 | 山东大学 | 一种水溶性聚乙二醇/聚乳酸多嵌段聚碳酸酯的制备方法 |
| US8992601B2 (en) | 2009-05-20 | 2015-03-31 | 480 Biomedical, Inc. | Medical implants |
| US9309347B2 (en) | 2009-05-20 | 2016-04-12 | Biomedical, Inc. | Bioresorbable thermoset polyester/urethane elastomers |
| GB2475778B (en) * | 2009-05-20 | 2013-03-13 | Arsenal Medical Inc | Medical implant |
| US20110319987A1 (en) | 2009-05-20 | 2011-12-29 | Arsenal Medical | Medical implant |
| EP3858299B1 (en) | 2009-05-20 | 2025-10-08 | Lyra Therapeutics, Inc. | Method of loading a self-expanding implant |
| EP2480588B1 (en) * | 2009-09-18 | 2018-04-25 | BTG International Limited | Reconstitutable reverse thermal gelling polymers |
| US9155722B2 (en) * | 2009-09-18 | 2015-10-13 | Protherics Salt Lake City, Inc. | Reconstitutable reverse thermal gelling polymers |
| HUE033386T2 (en) * | 2010-07-09 | 2017-11-28 | Innocore Tech B V | Release of Biodegradable Phase Separated Segmented Multiblock Copolymers and Biologically Active Polypeptides |
| EP2716669B1 (en) | 2011-06-03 | 2018-11-07 | Sumitomo Rubber Industries, Ltd. | Tire and gasket for syringes |
| US20130005829A1 (en) * | 2011-06-30 | 2013-01-03 | Advanced Technologies And Regenerative Medicine, Llc. | Segmented, epsilon-Caprolactone-Rich, Poly(epsilon-Caprolactone-co-p-Dioxanone) Copolymers for Medical Applications and Devices Therefrom |
| AU2012313984B2 (en) * | 2011-09-30 | 2016-02-11 | Covidien Lp | Reversible stiffening of light weight mesh |
| JP5763565B2 (ja) | 2012-02-02 | 2015-08-12 | 住友ゴム工業株式会社 | 表面改質方法及び表面改質弾性体 |
| JP5812935B2 (ja) | 2012-05-16 | 2015-11-17 | 住友ゴム工業株式会社 | 表面改質方法及び表面改質弾性体 |
| WO2014038688A1 (ja) | 2012-09-10 | 2014-03-13 | 住友ゴム工業株式会社 | 表面改質方法及び表面改質弾性体 |
| JP5620456B2 (ja) | 2012-11-20 | 2014-11-05 | 住友ゴム工業株式会社 | 表面改質方法及び表面改質弾性体 |
| JP6053482B2 (ja) | 2012-11-30 | 2016-12-27 | 住友ゴム工業株式会社 | 注射器用ガスケットの製造方法 |
| KR101560303B1 (ko) * | 2012-12-06 | 2015-10-14 | 주식회사 엘지화학 | 락타이드 공중합체, 이를 포함하는 수지 조성물 및 필름 |
| CN102977319B (zh) * | 2012-12-17 | 2014-09-03 | 中国科学院长春应用化学研究所 | 可降解聚乳酸两嵌段共聚物、制备方法及其在改性聚乳酸中的应用 |
| JP6105292B2 (ja) * | 2013-01-07 | 2017-03-29 | 住友ゴム工業株式会社 | 表面改質方法及び表面改質弾性体 |
| JP5816222B2 (ja) | 2013-04-25 | 2015-11-18 | 住友ゴム工業株式会社 | 表面改質方法及び表面改質弾性体 |
| CN103254411A (zh) * | 2013-06-07 | 2013-08-21 | 北京理工大学 | 一种高分子量聚乳酸的直接缩聚扩链制备方法 |
| JP5797239B2 (ja) | 2013-06-11 | 2015-10-21 | 住友ゴム工業株式会社 | 立体形状物の表面改質方法及び注射器用ガスケット |
| WO2014203668A1 (ja) | 2013-06-20 | 2014-12-24 | 住友ゴム工業株式会社 | 表面改質方法及び表面改質体 |
| WO2015030550A1 (ko) * | 2013-08-30 | 2015-03-05 | 주식회사 엘지화학 | 블록 공중합체 |
| EP3040354B1 (en) | 2013-08-30 | 2020-11-04 | LG Chem, Ltd. | Block copolymer |
| JP5820489B2 (ja) | 2014-01-06 | 2015-11-24 | 住友ゴム工業株式会社 | 表面改質方法及び表面改質弾性体 |
| JP6338504B2 (ja) | 2014-10-02 | 2018-06-06 | 住友ゴム工業株式会社 | 表面改質方法及び表面改質弾性体 |
| EP3034534A1 (en) * | 2014-12-17 | 2016-06-22 | PURAC Biochem BV | Substrates coated or bonded with a composition comprising a polyurethane |
| US12006395B2 (en) | 2015-01-02 | 2024-06-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Biodegradable polymer |
| JP6613692B2 (ja) | 2015-08-03 | 2019-12-04 | 住友ゴム工業株式会社 | 表面改質方法及び表面改質弾性体 |
| JP6551022B2 (ja) | 2015-08-03 | 2019-07-31 | 住友ゴム工業株式会社 | 表面改質方法及び表面改質体 |
| AU2018217064A1 (en) * | 2017-01-31 | 2019-08-08 | Veru Inc. | Compositions and methods for long term release of Gonadotropin-releasing hormone (GnRH) antagonists |
| EP3636292B1 (en) * | 2017-05-29 | 2023-03-01 | Educational Foundation Of Osaka Medical And Pharmaceutical University | Meniscus regeneration substrate |
| CN109734869B (zh) * | 2018-12-25 | 2021-05-11 | 广东工业大学 | 一种聚醚酯聚氨酯及其制备方法和应用 |
| AU2020357419B2 (en) | 2019-10-01 | 2025-12-04 | InnoCore Technologies Holding B.V. | Biodegradable, phase separated, thermoplastic multi-block copolymer |
| CN111205445B (zh) * | 2020-03-09 | 2021-07-16 | 成都颐合恒瑞医疗科技有限公司 | 一种双亲性嵌段共聚物、可吸收骨蜡及制法 |
| KR20240035841A (ko) * | 2021-08-19 | 2024-03-18 | 자빌 인코퍼레이티드 | 핵형성에 의한 폴리카프로락톤 분말의 제조 방법 |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04216822A (ja) * | 1990-02-21 | 1992-08-06 | Boehringer Ingelheim Kg | ヒドロキシカルボン酸に基づくポリエステルの製造方法 |
| US5202413A (en) * | 1993-02-16 | 1993-04-13 | E. I. Du Pont De Nemours And Company | Alternating (ABA)N polylactide block copolymers |
| JPH06298917A (ja) * | 1993-03-16 | 1994-10-25 | Sam Yang Co Ltd | 医療用生分解性コポリマー |
| JP2001509519A (ja) * | 1997-07-11 | 2001-07-24 | ライフ メディカル サイエンシズ インコーポレイテッド | 新規なポリマー組成物 |
| JP2002503524A (ja) * | 1998-02-23 | 2002-02-05 | マサチューセッツ インスティテュート オブ テクノロジー | 生分解性形状記憶ポリマー |
| JP2002517577A (ja) * | 1998-06-05 | 2002-06-18 | ポリガニックス ビー. ブイ. | 生体医用ポリウレタン、その調製方法及び使用方法 |
| JP2003327814A (ja) * | 2002-05-09 | 2003-11-19 | Daicel Chem Ind Ltd | 相溶性樹脂組成物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5066772A (en) * | 1987-12-17 | 1991-11-19 | Allied-Signal Inc. | Medical devices fabricated totally or in part from copolymers of recurring units derived from cyclic carbonates and lactides |
| US5133739A (en) * | 1990-02-06 | 1992-07-28 | Ethicon, Inc. | Segmented copolymers of ε-caprolactone and glycolide |
| NL9001984A (nl) * | 1990-09-10 | 1992-04-01 | Stamicarbon | Werkwijze voor het produceren van een voorwerp van een copolymeer van lactide en epsilon-caprolacton voor medische toepassingen. |
| US5236444A (en) * | 1992-10-27 | 1993-08-17 | United States Surgical Corporation | Absorbable polymers and surgical articles made therefrom |
-
2002
- 2002-07-16 EP EP02077878A patent/EP1382628A1/en not_active Withdrawn
-
2003
- 2003-07-16 JP JP2004521291A patent/JP2005533148A/ja active Pending
- 2003-07-16 CA CA2493375A patent/CA2493375C/en not_active Expired - Lifetime
- 2003-07-16 DE DE60320819T patent/DE60320819D1/de not_active Expired - Lifetime
- 2003-07-16 US US10/521,126 patent/US8674033B2/en active Active
- 2003-07-16 WO PCT/NL2003/000519 patent/WO2004007588A1/en not_active Ceased
- 2003-07-16 ES ES03764248T patent/ES2305512T3/es not_active Expired - Lifetime
- 2003-07-16 CN CN03819564XA patent/CN1675281B/zh not_active Expired - Lifetime
- 2003-07-16 AT AT03764248T patent/ATE394439T1/de not_active IP Right Cessation
- 2003-07-16 EP EP03764248A patent/EP1551899B1/en not_active Expired - Lifetime
- 2003-07-16 AU AU2003247231A patent/AU2003247231B2/en not_active Expired
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04216822A (ja) * | 1990-02-21 | 1992-08-06 | Boehringer Ingelheim Kg | ヒドロキシカルボン酸に基づくポリエステルの製造方法 |
| US5202413A (en) * | 1993-02-16 | 1993-04-13 | E. I. Du Pont De Nemours And Company | Alternating (ABA)N polylactide block copolymers |
| JPH06298917A (ja) * | 1993-03-16 | 1994-10-25 | Sam Yang Co Ltd | 医療用生分解性コポリマー |
| JP2001509519A (ja) * | 1997-07-11 | 2001-07-24 | ライフ メディカル サイエンシズ インコーポレイテッド | 新規なポリマー組成物 |
| JP2002503524A (ja) * | 1998-02-23 | 2002-02-05 | マサチューセッツ インスティテュート オブ テクノロジー | 生分解性形状記憶ポリマー |
| JP2002517577A (ja) * | 1998-06-05 | 2002-06-18 | ポリガニックス ビー. ブイ. | 生体医用ポリウレタン、その調製方法及び使用方法 |
| JP2003327814A (ja) * | 2002-05-09 | 2003-11-19 | Daicel Chem Ind Ltd | 相溶性樹脂組成物 |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005320426A (ja) * | 2004-05-07 | 2005-11-17 | National Institute For Materials Science | ポリリンゴ酸共重合体の製造方法 |
| JPWO2006100844A1 (ja) * | 2005-03-18 | 2008-08-28 | 三井化学株式会社 | 生分解性を有する水環境応答型ポリマー、その製造方法および水崩壊性材料 |
| JP2010506991A (ja) * | 2006-10-18 | 2010-03-04 | コントロールド・セラピューティクス(スコットランド)・リミテッド | 生体吸収性ポリマー |
| WO2010101240A1 (ja) * | 2009-03-06 | 2010-09-10 | 国立大学法人岡山大学 | 生分解性多孔質中空微粒子、その製造方法および用途 |
| JP5574445B2 (ja) * | 2009-03-06 | 2014-08-20 | 国立大学法人 岡山大学 | 生分解性多孔質中空微粒子、その製造方法および用途 |
| WO2012133608A1 (ja) * | 2011-03-30 | 2012-10-04 | 東レ株式会社 | 生分解性粒子、血管塞栓材料及び生分解性粒子の製造方法 |
| US8871873B2 (en) | 2011-03-30 | 2014-10-28 | Toray Industries, Inc. | Biodegradable particle, vascular embolization material and method for producing biodegradable particles |
| KR101889586B1 (ko) * | 2011-07-22 | 2018-09-20 | 이노코어 테크놀로지스 비.브이. | 생물학적 활성 화합물의 조절된 방출을 위한 생분해성, 반-결정, 상 분리, 열 가소성 플라스틱의 멀티-블록 공중합체 |
| JP2014521762A (ja) * | 2011-07-22 | 2014-08-28 | インノコア テクノロジーズ ビー.ブイ. | 生物活性化合物の制御放出のための生物分解性、半結晶性、相分離、熱可塑性マルチブロックコポリマー |
| JP2017141477A (ja) * | 2011-07-22 | 2017-08-17 | インノコア テクノロジーズ ビー.ブイ. | 生物活性化合物の制御放出のための生物分解性、半結晶性、相分離、熱可塑性マルチブロックコポリマー |
| JP2015511649A (ja) * | 2012-03-12 | 2015-04-20 | エシコン・インコーポレイテッドEthicon, Inc. | セグメント化した、半結晶性ポリ(ラクチド−コ−ε−カプロラクトン)吸収性コポリマー |
| WO2020122096A1 (ja) * | 2018-12-13 | 2020-06-18 | 東レ株式会社 | 医療用成形体、医療機器、神経再生誘導チューブ |
| JPWO2020122096A1 (ja) * | 2018-12-13 | 2021-11-04 | 東レ株式会社 | 医療用成形体、医療機器、神経再生誘導チューブ |
| JP7484167B2 (ja) | 2018-12-13 | 2024-05-16 | 東レ株式会社 | 医療用成形体、医療機器、神経再生誘導チューブ |
| US12440598B2 (en) | 2018-12-13 | 2025-10-14 | Toray Industries, Inc. | Medical molded article, medical device, and nerve guidance conduit |
| JP2022540717A (ja) * | 2019-07-19 | 2022-09-16 | エボニック オペレーションズ ゲーエムベーハー | マルチブロック形状記憶生体吸収性ポリマー |
| JP7735247B2 (ja) | 2019-07-19 | 2025-09-08 | エボニック オペレーションズ ゲーエムベーハー | マルチブロック形状記憶生体吸収性ポリマー |
| WO2024029491A1 (ja) * | 2022-08-01 | 2024-02-08 | Dic株式会社 | 3-ヒドロキシ酪酸からなるコポリエステル及びその製造方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2493375A1 (en) | 2004-01-22 |
| US8674033B2 (en) | 2014-03-18 |
| US20070003592A1 (en) | 2007-01-04 |
| EP1382628A1 (en) | 2004-01-21 |
| WO2004007588A1 (en) | 2004-01-22 |
| ES2305512T3 (es) | 2008-11-01 |
| ATE394439T1 (de) | 2008-05-15 |
| CA2493375C (en) | 2012-01-03 |
| CN1675281B (zh) | 2010-05-12 |
| AU2003247231A1 (en) | 2004-02-02 |
| CN1675281A (zh) | 2005-09-28 |
| EP1551899B1 (en) | 2008-05-07 |
| AU2003247231B2 (en) | 2008-07-31 |
| DE60320819D1 (de) | 2008-06-19 |
| EP1551899A1 (en) | 2005-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005533148A (ja) | 生分解性の相分離したセグメント化多ブロック共重合体 | |
| DK2859887T3 (en) | BIODEGRADABLE PHASE Separated, SEGMENTED MULTIBLOCK COPOLYMERS AND RELEASE OF BIOLOGICALLY ACTIVE POLYPEPTIDES | |
| CA2294711C (en) | Novel polymeric compositions | |
| JP3739501B2 (ja) | 吸収され、生物学的に適合し得るセグメントコポリマー及びその製造方法 | |
| JP4907359B2 (ja) | 生分解可能なマルチブロックコポリマー | |
| EP0636639B1 (en) | Copolymers of an aromatic anhydride and aliphatic ester | |
| EP2203500B1 (en) | Absorbable polymer formulations | |
| AU738400B2 (en) | Absorbable polyalkylene diglycolates | |
| MXPA97003652A (en) | Absalbib polyalykylene diglycollates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060706 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060707 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20090129 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090213 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090511 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100707 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20101001 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20101008 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110404 |